TheraPsil is a non-Profit Coalition advocating for psilocybin-assisted therapy for end-of-life distress.
TheraPsil's focus is on the provision of compassionate treatment for Canadians in palliative care who suffer from end-of-life distress. End-of-life distress is best described as the combination of anxiety, depression, hopelessness, and demoralization experienced by patients who receive a diagnosis of an incurable illness, or who are in remission from diseases such as cancer, HIV/AIDS, or heart disease. As research in psychedelic medicine matures, TheraPsil will further expand their services to include others who may benefit from psilocybin.
TheraPsil’s 4 Pillar Mission
- COMPASSIONATE ACCESS: Establish safe, compassionate, and legal access to psychedelic-assisted therapy for those in medical need.
- PUBLIC EDUCATION: Increase awareness of general public and health care professionals about the merits and limitations of psychedelic-assisted therapy.
- PROFESSIONAL TRAINING: Developing safe, simple, and effective protocols for credentialed health professionals across Canada to deliver psilocybin-assisted therapy, in collaboration with other active organizations.
- RESEARCH: Facilitate research and evaluation, in collaboration with Canadian and international partners.